Dapagliflozin Tecnigene 10 mg Film-Coated Tablets

2. What you need to know before taking Dapagliflozin TecniGen

Do not take Dapagliflozin TecniGen

• if you are allergic to dapagliflozin or any of the other ingredients of this medication (listed in section 6).

Warnings and precautions

Contact a doctor or the nearest hospital immediately:

Diabetic ketoacidosis:

• If you have diabetes and experience nausea or vomiting, have stomach pain, excessive thirst, rapid and deep breathing, confusion, drowsiness or unusual fatigue, sweet smell on your breath, a sweet or metallic taste in your mouth, or a different smell in your urine or sweat, or rapid weight loss.
• The above symptoms may be a sign of "diabetic ketoacidosis" - a rare but serious, potentially life-threatening problem that occurs with diabetes due to an increase in "ketone bodies" in your urine or blood, which is detected in tests.
• The risk of developing diabetic ketoacidosis may be increased with prolonged fasting, excessive alcohol consumption, dehydration, sudden reductions in insulin dose, or a greater need for insulin due to major surgery or serious illness.
• When you are being treated with dapagliflozin, diabetic ketoacidosis may occur even if your blood sugar levels are normal.

If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital immediately and do not take this medication.

Necrotizing fasciitis of the perineum:

• Consult your doctor immediately if you experience a combination of symptoms such as pain, tenderness, redness, or swelling of the genitals or the area between the genitals and the anus, with fever or general malaise. These symptoms could be a sign of a rare but serious, potentially life-threatening infection called necrotizing fasciitis of the perineum or Fournier's gangrene, which destroys tissue under the skin. Fournier's gangrene requires immediate treatment.

Consult your doctor, pharmacist, or nurse before starting to take Dapagliflozin TecniGen:

• If you have "type 1 diabetes" - the type that usually occurs when you are young and your body does not produce any insulin. Dapagliflozin should not be used to treat this condition.
• If you have diabetes and have any kidney problems - your doctor may prescribe an additional medication or a different one to control blood sugar levels.
• If you have any liver problems - your doctor may start with a lower dose.
• If you are taking medications to lower your blood pressure (antihypertensives) or have a history of low blood pressure (hypotension). More information is included later in "Other medications and Dapagliflozin TecniGen"
• If you have very high blood sugar levels that can cause dehydration (loss of too much fluid from the body). Possible signs of dehydration are listed in section 4. Inform your doctor before starting to take dapagliflozin if you experience any of these signs.
• If you have or develop nausea (feeling of vomiting), vomiting, or fever, or are unable to eat or drink. These conditions can cause dehydration. Your doctor may ask you to stop taking dapagliflozin until you recover to prevent dehydration.
• If you frequently experience urinary tract infections.

If any of the above situations apply to you (or you are unsure), talk to your doctor, pharmacist

or nurse before taking dapagliflozin.

Diabetes and foot care

If you have diabetes, it is essential that you regularly check your feet and follow any other foot care advice provided by your healthcare professional.

Glucose in urine

Due to how dapagliflozin works, your urine will test positive for glucose while you are taking this medication.

Children and adolescents

Dapagliflozin can be used in children aged 10 years or older to treat type 2 diabetes. There

is no data available in children under 10 years of age.

Dapagliflozin is not recommended in children or adolescents under 18 years of age to treat heart failure or chronic kidney disease, as it has not been studied in these patients.

Other medications and Dapagliflozin TecniGen

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medications.

Especially inform your doctor:

• If you are taking a medication used to remove fluid from the body (diuretic).
• If you are taking other medications that lower blood sugar levels, such as insulin or a "sulfonylurea" type medication. Your doctor may decide to reduce the dose of these medications to avoid low blood sugar levels (hypoglycemia).
• If you are taking lithium, as dapagliflozin may reduce the amount of lithium in your blood.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

You should stop taking this medication if you become pregnant, as its use is not recommended during the second and third trimesters of pregnancy. Consult your doctor about the best way to control your blood sugar levels during pregnancy.

Consult your doctor if you want to breastfeed or are breastfeeding before taking this medication. Do not use dapagliflozin during breastfeeding. It is unknown whether this medication passes into human breast milk.

Driving and using machines

Dapagliflozin has no significant influence on the ability to drive or use machines.

Taking this medication with other medications called sulfonylureas or with insulin may cause low blood sugar levels (hypoglycemia), which can cause symptoms such as trembling, sweating, and vision changes that can affect your ability to drive or use machines.

Do not drive or use tools or machines if you feel dizzy while taking dapagliflozin.

3. How to take Dapagliflozin TecniGen

Follow the instructions for taking this medication exactly as indicated by your doctor. If you are unsure, consult your doctor, pharmacist, or nurse again.

What dose should you take

• The recommended dose is one 10 mg tablet per day.
• Your doctor may start with a dose of 5 mg if you have a liver problem.
• Your doctor will prescribe the correct dose for you.

How to take this medication

• Swallow the tablet whole with a half glass of water.
• You can take the tablet with or without food.
• You can take the tablet at any time of day. However, try to take it at the same time each day. This will help you remember to take it.

Your doctor may prescribe dapagliflozin along with another medication(s). Remember to take these other medication(s) as instructed by your doctor. This will help you get the best results for your health.

Diet and exercise can help your body use blood sugar better. If you have diabetes, it is essential that you follow any diet and exercise program recommended by your doctor while taking dapagliflozin.

If you take more Dapagliflozin TecniGen than you should

If you take more dapagliflozin tablets than you should, consult your doctor or go to the hospital

immediately. Bring the medication package with you. In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Dapagliflozin TecniGen

What you should do if you forget to take a tablet depends on how much time is left until your next dose.

• If there are 12 hours or more left until your next dose, take a dose of dapagliflozin as soon as you remember. Then take the next dose at the usual time.
• If there are less than 12 hours left until the next dose, skip the missed dose. Take the next dose at the usual time.
• Do not take a double dose of dapagliflozin to make up for missed doses.

If you stop taking Dapagliflozin TecniGen

Do not stop taking dapagliflozin without first consulting your doctor. If you have diabetes, your blood sugar levels may increase without this medication.

If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone gets them.

Contact a doctor or the nearest hospital immediately if you experience any of the following side effects:

• Angioedema,seen very rarely (may affect up to 1 in 10,000 people).

These are the signs of angioedema:

• swelling of the face, tongue, or throat
• difficulty swallowing
• hives and breathing problems

• Diabetic ketoacidosis, rare in patients with type 2 diabetes (may affect up to 1 in 1,000 people)

These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions):

• increase in "ketone bodies" in your urine or blood
• nausea or vomiting
• stomach pain
• excessive thirst
• rapid and deep breathing
• confusion
• drowsiness and unusual fatigue
• sweet smell on your breath, a sweet or metallic taste in your mouth, or a different smell in your urine or sweat
• rapid weight loss

This can occur regardless of blood sugar levels. Your doctor should decide whether to temporarily or permanently stop your treatment with dapagliflozin.

• Necrotizing fasciitis of the perineumor Fournier's gangrene, a rare but serious infection of the soft tissues of the genitals or the area between the genitals and the anus.

Stop taking dapagliflozin and consult a doctor immediately if you notice any of these serious side effects:

• Urinary tract infection, common (may affect up to 1 in 10 people).

These are the signs of a severe urinary tract infection:

• fever and/or chills
• feeling of burning while urinating
• back pain or side pain.

Although it is not common, if you notice blood in your urine, inform your doctor immediately.

Contact your doctor as soon as possible if you experience any of the following side effects:

• Low blood sugar levels(hypoglycemia), very common (may affect more than 1 in 10 people) in patients with diabetes who take this medication along with a sulfonylurea or insulin

The signs of low blood sugar levels are:

• chills, sweating, feeling of great anxiety, rapid heartbeat
• feeling of hunger, headache, vision changes
• mood changes or feeling of confusion.

Your doctor will explain how to treat low blood sugar levels and what to do if you experience any of the above symptoms.

Other side effects of treatment with dapagliflozin:

Common

• genital infections (candidiasis) of the penis or vagina (signs may include irritation, itching, and abnormal discharge or odor)
• back pain
• increased urination or need to urinate more frequently
• changes in cholesterol or lipid levels in the blood (observed in tests)
• increases in red blood cell count in the blood (observed in tests)
• decreases in renal clearance of creatinine (observed in tests) at the start of treatment
• dizziness
• rash

Uncommon (may affect up to 1 in 100 people)

• excessive loss of fluids from the body (dehydration, signs may include a very dry or sticky mouth, reduced or absent urination, or rapid heartbeat)
• thirst
• constipation
• nocturnal awakenings to urinate
• dry mouth
• weight loss
• increased creatinine (observed in blood tests) at the start of treatment
• increased urea (observed in blood tests)

Rare

• kidney inflammation (tubulointerstitial nephritis)

Reporting side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Dapagliflozin TecniGen

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the package after CAD. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at the pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Container Content and Additional Information

Composition of Dapagliflozina TecniGen

• The active ingredient is dapagliflozina.

Each film-coated tablet (tablet) of Dapagliflozina TecniGen 5

mg contains dapagliflozina propanodiol monohydrate equivalent to 5 mg of

dapagliflozina.

Each film-coated tablet (tablet) of Dapagliflozina TecniGen 10

mg contains dapagliflozina propanodiol monohydrate equivalent to 10 mg of

dapagliflozina.

• The other components are:

• tablet core: mannitol, silicified microcrystalline cellulose, crospovidone, talc, magnesium stearate.
• coating: Poly (vinyl alcohol), titanium dioxide (E171), polyethylene glycol/macrogol, talc, yellow iron oxide (E172).

Appearance of the Product and Container Content

The film-coated tablets of Dapagliflozina TecniGen 5 mg are yellow and round, with a diameter of 7.0 mm ± 0.2 mm, and are engraved with "5" on one side.

The film-coated tablets of Dapagliflozina TecniGen 10 mg are yellow and oval, with a length of 11.5 mm ± 0.2 mm and a width of 7.0 mm ± 0.2 mm.

Dapagliflozina TecniGen 5 mg film-coated tablets are available in OPA-Alu blisters in packs of 14 and 28 film-coated tablets.

Dapagliflozina TecniGen 10 mg film-coated tablets are available in OPA-Alu blisters in packs of 14 or 28 film-coated tablets.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Tecnimede España Industria Farmacéutica, S.A.

Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,

28108 Alcobendas (Madrid)

Spain

Manufacturer

Atlantic Pharma - Produções Farmacêuticas S.A.

Rua da Tapada Grande nº 2, Abrunheira

2710-089 Sintra

Portugal

Or

Tecnimede - Sociedade Técnico-Medicinal S.A.

Quinta da Cerca, Caixaria

2565-187 Dois Portos

Portugal

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Portugal: Dapagliflozina Tecnigen

Italy: Dapagliflozin Tecnigen

Cyprus: Dapagliflozin Farmoz

Date of the last revision of thisleaflet:April 2024

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)